The Use of an Open Label Placebo to Treat Cancer Related Fatigue in Cancer Survivors

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this randomized-controlled, crossover pilot trial is to evaluate the feasibility, acceptability and effects of a non-deceptive (open-label) administration of placebo pills for treating cancer related fatigue (CRF). If significant effects are found, the investigators will later determine if the presence of a COMT Val18Met genotype variant predicts placebo responses.
Epistemonikos ID: d8266e7c27823fabdb33d30b3e994d4bf76e93ad
First added on: May 12, 2024